Moxetumomab Pasudotox-tdfk and Paricalcitol Capsules
Determining the interaction of Moxetumomab Pasudotox-tdfk and Paricalcitol Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Paricalcitol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Paricalcitol Injection
- Moxetumomab Pasudotox-tdfk-Paricalcitol Intravenous
- Moxetumomab Pasudotox-tdfk-Parlodel
- Moxetumomab Pasudotox-tdfk-Parnate
- Moxetumomab Pasudotox-tdfk-Paromomycin
- Moxetumomab Pasudotox-tdfk-Paromomycin Sulfate
- Paricalcitol Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Paricalcitol Capsules-Moxifloxacin
- Paricalcitol Capsules-Moxifloxacin (Systemic)
- Paricalcitol Capsules-Moxifloxacin Hydrochloride
- Paricalcitol Capsules-Moxifloxacin Injection
- Paricalcitol Capsules-Moxifloxacin Intravenous